4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0000950170-24-073969
Senior VP, Chief Pharma Dev. sold 2,000 shares at $285.00 ($570,000)
- Senior VP, Chief Pharma Dev. acquired 2,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Waltermire Robert E. Senior VP, Chief Pharma Dev. | 2024-06-12 | Option exercise | +2,000 | $87.92 | $175,840 | 7,500 | D |
| Waltermire Robert E. Senior VP, Chief Pharma Dev. | 2024-06-12 | Sale | −2,000 | $285.00 | $570,000 | 5,500 | D |
| Derivatives | |||||||
| Waltermire Robert E. Senior VP, Chief Pharma Dev. | 2024-06-12 | Option exercise · Stock Option (Right to Buy) | −2,000 | 15,200 | D | ||
| Open-market sales · 2,000 sh · avg $285.00 · $570,000 | |||||||
Loading xslF345X05/ownership.xml…